GSR and attention deficit-hyperactivity disorder: Out of 84 ADHD probands available for post-therapeutic follow-up, 52 received MPH, while 32 were treated with ATX based on the age at presentation, presenting symptoms, and availability of the medicine, and the treatment efficacy was tested in the probands having different GluR genotypes.